CARLSON CAPITAL L P - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 72 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
CARLSON CAPITAL L P ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$82,600
-80.0%
70,000
+27.3%
0.01%
-80.6%
Q3 2022$414,000
+1.0%
55,000
-15.4%
0.03%
+10.7%
Q2 2022$410,000
+83.0%
65,000
+140.7%
0.03%
+86.7%
Q1 2022$224,000
-47.4%
27,000
-67.1%
0.02%
-37.5%
Q4 2021$426,00082,0000.02%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders